Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea

Clinical Therapeutics

Volumn 26, Issue 10, 2004, Pages 1644-1651

  Kuge, Tomoo ^a   Shibata, Takashi ^a   Willett, Michael S ^b  

^a Taiko Pharmaceutical Company Ltd   (Japan)

^b Advanced Biomedical Research   (United States)

Author keywords

acute nonspecific diarrhea; antidiarrheal; antispasmodic; loperamide; Seirogan; wood creosote

Indexed keywords

ANTIDIARRHEAL AGENT; CREOSOTE; LOPERAMIDE; SEIROGAN; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FECES ANALYSIS; FEVER; HISPANIC; HUMAN; LABORATORY TEST; LOADING TEST; MEDICINAL PLANT; MEXICO; MULTICENTER STUDY; NAUSEA; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT OUTCOME; UNITED STATES; VOMITING; WOOD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDIARRHEALS; COLIC; CREOSOTE; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOPERAMIDE; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 10444253906     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2004.10.001     Document Type: Article

References (13)

1. Ogata N., and Baba T. Analysis of beechwood creosote by gas chromatography-mass spectrometry and highperformance liquid chromatography Res Commun Chem Palhol Pharmacol 66 1989 411 423
2. Haller J.S. Jr Creosote: A short history of its medicinal uses Conn Med 54 1990 502 507
3. Kuge T., Shibata T., and Willett M.S. Wood creosote, the principal active ingredient of seirogan, an herbal antidiarrheal medicine: A single-dose, dose-escalation safety andpharmacokinetic study Pharmacotherapy 23 2003 1391 1400
4. US Dept of Health and Human Services (DHHS) Public Health Service, National Toxicology Program 10th ed Report on Carcinogens 2002 DHHS Washington, DC
5. Kuge T., Shibata T., and Willett M.S. Lack of oncogenicity of wood creosote, the principal active ingredient of seirogan, an herbal antidiarrheal medication, in Sprague-Dawley rats Int J Toxicol 10 2001 297 305
6. Ogata N., Baba T., and Shibata T. Demonstration of antidiarrheal and antimotility effects of wood creosote Pharmacology 46 1993 173 180
7. Ogata N., and Shibata T. Antidiarrheal activity of wood creosote: Inhibition of muscle contraction and enterotoxininduced fluid secretion in rabbit small intestine Pharmacology 62 2001 181 187
8. Greenwood-Van Meerveld B., Tyler K.R., Venkova K., and Kuge T. Comparison of the antidiarrheal effects of wood creosote and loperamide in the rat jejunum and colon in vitro Biol Pharm Bull 23 2000 952 956
9. Kuge T., Venkova K., and Greenwood-Van Meerveld B. Effects of seirogan (wood creosote) on propulsive colonic motility and stool characteristics in ambulatory minipigs Dig Dis Sci 47 2002 2651 2656
10. Ataka K., Kuge T., Venkova K., and Greenwood-Van Meerveld B. Seirogan (wood creosote) inhibits stressinduced ion secretion in rat intestinal epithelium Dig Dis Sci 48 2003 1303 1309
11. Kuge T., Shibata T., and Willett M.S. Multiple-dose escalation, safety, and tolerability study of wood creosote, the principal active ingredient of seirogan, an herbal antidiarrhealmedication, in healthy subjects J Clin Pharmacol 43 2003 284 290
12. Data on file, study nos. TA-107, TA-108, TA-109, and TA114 2004 Taiko Pharmaceutical Co., Ltd.
13. Available at National Center for Infectious Diseases Travelers' diarrhea Accessed July 6, 2004 2004 Centers for Disease Control and Prevention Atlanta, Ga